Home The Word Brain	My Amedeo FAQ Privacy About
	Amedeo C49 English + 你好 (nǐ hǎo) = limitless possibilities. Start learning Mandarin Chinese today—for free, forever. Amedeo C49 is completely free, for life. Next week: +49.

Chronic Renal Failure

Free Subscription Articles published in N Engl J Med Retrieve available abstracts of 28 articles: HTML format

Single Articles

September 2025
1. KAWAI T, Riella LV
   Porcine Xenotransplantation in End-Stage Kidney Disease. Reply.
   N Engl J Med. 2025;393:930-931.
   PubMed    
   
   
   
2. MELILLI E, Garcia Romero E
   Porcine Xenotransplantation in End-Stage Kidney Disease.
   N Engl J Med. 2025;393:930.
   PubMed    
   
   
   
3. WEINRAUCH LA, D'Elia JA
   Porcine Xenotransplantation in End-Stage Kidney Disease.
   N Engl J Med. 2025;393:929-930.
   PubMed    
   
   
   
4. JIANG Q, Ye L, Wu J
   Porcine Xenotransplantation in End-Stage Kidney Disease.
   N Engl J Med. 2025;393:929.
   PubMed    
   
   
   August 2025
5. ZOCCALI C, Mallamaci F
   Combination Therapy for Chronic Kidney Disease and Type 2 Diabetes - A Promising Prelude.
   N Engl J Med. 2025;393:601-602.
   PubMed    
   
   
   June 2025
6. HERRINGTON WG, Staplin N, Haynes R
   Long-Term Effects of Empagliflozin in Chronic Kidney Disease. Reply.
   N Engl J Med. 2025;392:2285-2286.
   PubMed    
   
   
   
7. YOSHIMOTO N, Azegami T, Hayashi K
   Long-Term Effects of Empagliflozin in Chronic Kidney Disease.
   N Engl J Med. 2025;392:2285.
   PubMed    
   
   
   
8. ILANY J
   Long-Term Effects of Empagliflozin in Chronic Kidney Disease.
   N Engl J Med. 2025;392:2284-2285.
   PubMed    
   
   
   
9. AGARWAL R, Green JB, Heerspink HJL, Mann JFE, et al
   Finerenone with Empagliflozin in Chronic Kidney Disease and Type 2 Diabetes.
   N Engl J Med. 2025 Jun 5. doi: 10.1056/NEJMoa2410659.
   PubMed     Abstract available
   
   
   April 2025
10. KOUKOUNAS KG, Dixit MN, Thorsness R, Patzer RE, et al
    Performance of Dialysis Facilities after Health-Equity Scoring Incentive.
    N Engl J Med. 2025;392:1657-1659.
    PubMed    
    
    
    
11. GBADEGESIN RA, Adu D, Ojo A
    APOL1 Bi- and Monoallelic Variants and Chronic Kidney Disease in West Africans. Reply.
    N Engl J Med. 2025;392:1664.
    PubMed    
    
    
    
12. INGWILLER M
    APOL1 Bi- and Monoallelic Variants and Chronic Kidney Disease in West Africans.
    N Engl J Med. 2025;392:1663-1664.
    PubMed    
    
    
    
13. ZHOU XJ
    APOL1 Bi- and Monoallelic Variants and Chronic Kidney Disease in West Africans.
    N Engl J Med. 2025;392:1663.
    PubMed    
    
    
    February 2025
14. LEAF DE, Bansal N
    Another Win for SGLT2 Inhibitors in Chronic Kidney Disease.
    N Engl J Med. 2025;392:822-823.
    PubMed    
    
    
    
15. KAWAI T, Williams WW, Elias N, Fishman JA, et al
    Xenotransplantation of a Porcine Kidney for End-Stage Kidney Disease.
    N Engl J Med. 2025 Feb 7. doi: 10.1056/NEJMoa2412747.
    PubMed     Abstract available
    
    
    November 2024
16. VIVANTE A
    Genetics of Chronic Kidney Disease. Reply.
    N Engl J Med. 2024;391:1968.
    PubMed    
    
    
    
17. KNEBELMANN B, Haydock L
    Genetics of Chronic Kidney Disease.
    N Engl J Med. 2024;391:1967-1968.
    PubMed    
    
    
    
18. MARCHINI M
    Genetics of Chronic Kidney Disease.
    N Engl J Med. 2024;391:1967.
    PubMed    
    
    
    
19. CHANG KT, Chiu CC, Lin HY
    Genetics of Chronic Kidney Disease.
    N Engl J Med. 2024;391:1966-1967.
    PubMed    
    
    
    
20. PERKOVIC V, Tuttle KR, Pratley R
    Semaglutide for Chronic Kidney Disease in Type 2 Diabetes. Reply.
    N Engl J Med. 2024;391:1757.
    PubMed    
    
    
    
21. DA HORA PASSOS R, Narciso RC, da Silva AA
    Semaglutide for Chronic Kidney Disease in Type 2 Diabetes.
    N Engl J Med. 2024;391:1757.
    PubMed    
    
    
    October 2024
22. GBADEGESIN RA, Ulasi I, Ajayi S, Raji Y, et al
    APOL1 Bi- and Monoallelic Variants and Chronic Kidney Disease in West Africans.
    N Engl J Med. 2024 Oct 26. doi: 10.1056/NEJMoa2404211.
    PubMed     Abstract available
    
    
    
23. HERRINGTON WG, Staplin N, Agrawal N, Wanner C, et al
    Long-Term Effects of Empagliflozin in Patients with Chronic Kidney Disease.
    N Engl J Med. 2024 Oct 25. doi: 10.1056/NEJMoa2409183.
    PubMed     Abstract available
    
    
    
24. DURAND CM, Massie A, Florman S, Liang T, et al
    Safety of Kidney Transplantation from Donors with HIV.
    N Engl J Med. 2024;391:1390-1401.
    PubMed     Abstract available
    
    
    August 2024
25. VIVANTE A
    Genetics of Chronic Kidney Disease.
    N Engl J Med. 2024;391:627-639.
    PubMed    
    
    
    May 2024
26. PERKOVIC V, Tuttle KR, Rossing P, Mahaffey KW, et al
    Effects of Semaglutide on Chronic Kidney Disease in Patients with Type 2 Diabetes.
    N Engl J Med. 2024 May 24. doi: 10.1056/NEJMoa2403347.
    PubMed     Abstract available
    
    
    April 2024
27. VAZQUEZ MA, Oliver G, Amarasingham R, Sundaram V, et al
    Pragmatic Trial of Hospitalization Rate in Chronic Kidney Disease.
    N Engl J Med. 2024;390:1196-1206.
    PubMed     Abstract available
    
    
    March 2024
28. XU BP, Wang XT
    Green Dialysis Effluent and Plasma.
    N Engl J Med. 2024;390:e27.
    PubMed    
    
    

Thank you for your interest in scientific medicine.

AMEDEO Chronic Renal Failure is free of charge.